GRX-MCiPS4F-A2-ETO2-GLIS2
GENYOi006-A-1
General
Cell Line |
|
| hPSCreg name | GENYOi006-A-1 |
| Cite as: | GENYOi006-A-1 (RRID:CVCL_YN83) |
| Alternative name(s) |
GRX-MCiPS4F-A2-ETO2-GLIS2
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
GENYOi006-A (GRX-MCiPS4F-A2) GENYOi006-A-2 (GRX-MCiPS4F-A2-NEO) WAe001-A-10 (H1_RB1ex3_G3) RUCDRi002-A-63 (LVIP05-RB1-CS1) WAe001-A-11 (H1_RB1ex3_G4) RUCDRi002-A-64 (LVIP05-RB1-CS2) WAe001-A-31 (H1_RB1ex1_D6) RUCDRi002-A-65 (LVIP05-RB1-CS3) WAe001-A-32 (H1_RB1ex1_E9) |
| Last update | 15th June 2020 |
| User feedback | |
Provider |
|
| Generator | Centre for Genomics and Oncological Research (GENYO) |
| Owner | Centre for Genomics and Oncological Research (GENYO) |
| Derivation country | Spain |
External Databases |
|
| BioSamples | SAMEA6438547 |
| Cellosaurus | CVCL_YN83 |
| Wikidata | Q93560863 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | male |
| Ethnicity | Spaniard Caucasian |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Karyotyping (Donor) |
|
| Has the donor karyotype been analysed? |
Yes
46, xy
Karyotyping method:
G-Banding
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
| BioSamples | SAMEA6438546 |
Ethics
Also have a look at the ethics information for the parental line
GENYOi006-A
.
| Is there an MTA available for the cell line? | No |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | Dr. Tanja Gruber (Memphis, USA) |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
GENYOi006-A.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
| Is reprogramming vector detectable? |
No |
| Methods used |
RT-PCR
|
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
EDTA
|
| O2 Concentration | 20 % |
| CO2 Concentration | 5 % |
| Medium |
Essential 8™
|
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
| Alkaline Phosphatase |
Yes |
|||||
| NANOG |
Yes |
|
||||
| SOX2 |
Yes |
|
||||
| SSEA-3 |
Yes |
|
||||
| SSEA-4 |
Yes |
|
||||
| TRA 1-60 |
Yes |
|
||||
| POU5F1 (OCT-4) |
Yes |
|
|
Differentiation Potency
Microbiology / Virus Screening |
|
| Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
46, xy
Karyotyping method:
G-Banding
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.